CME analyst estimates
CME Group (CME) analyst ratings, the average price target and its range, and every firm's latest call.
CME analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 22, 2026 | Barclays | CME Group price target raised to $321 from $281 at Barclays | $321.00 |
| Oct 22, 2026 | CLSA | JPMorgan Double Upgrades CME Group (CME) to Overweight | $367.00 |
| Oct 22, 2026 | Morgan Stanley | CME Group price target raised to $359 from $337 at Morgan Stanley | $359.00 |
| Oct 22, 2026 | Wells Fargo | CME Group price target raised to $333 from $315 at Wells Fargo | $333.00 |
| Oct 22, 2026 | Piper Sandler | CME Group price target raised to $330 from $295 at Piper Sandler | $330.00 |
| Oct 14, 2026 | Wells Fargo | CME Group price target raised to $315 from $301 at Wells Fargo | $315.00 |
| Oct 9, 2026 | Morgan Stanley | CME Group price target raised to $337 from $330 at Morgan Stanley | $337.00 |
| Oct 7, 2026 | Barclays | CME Group price target raised to $281 from $270 at Barclays | $281.00 |
| Oct 5, 2026 | UBS | CME Group (CME) PT Raised to $270 at UBS | $270.00 |
| Oct 1, 2026 | Wells Fargo | CME Group initiated with an Overweight at Wells Fargo | $301.00 |
| Aug 19, 2026 | Deutsche Bank | CME Group downgraded to Hold from Buy at Deutsche Bank | $270.00 |
| Jul 23, 2026 | Morgan Stanley | CME Group price target raised to $330 from $324 at Morgan Stanley | $330.00 |
| Jul 15, 2026 | Piper Sandler | CME Group price target lowered to $295 from $329 at Piper Sandler | $295.00 |
| Jul 10, 2026 | Morgan Stanley | CME Group price target lowered to $324 from $353 at Morgan Stanley | $324.00 |
| Jul 6, 2026 | UBS | CME Group price target lowered to $260 from $310 at UBS | $260.00 |
- 14 firms rate CME: 8 buy, 5 hold, 1 sell.
- The average price target is $321.43 from 7 analysts, from $270.00 to $367.00.
Updated 2026-11-02 17:51 UTC